Showing results (41-50 of 410) with videos related to
Sort By:
Pageof 41
Cancer Clinical Trials|January 1, 1980
Phase I-II clinical trial of gallium nitrate (NSC-15200)M K Samson, R J Fraile, L H Baker, et al.American Journal of Clinical Oncology|April 1, 1985
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trialM K Samson, C D Haas, L H Baker, et al.Cancer|July 1, 1975
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaP Seifert, L H Baker, M L Reed, et al.Cancer Treatment Reports|September 1, 1976
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanomaM K Samson, L H Baker, R M Izbicki, et al.Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patientsG G Chabot, L E Flaherty, M Valdivieso, et al.JAMA|August 9, 1976
Recurrent conjugal neuralgia caused by Herpesvirus hominis type 2D R Hinthorn, L H Baker, D A Romig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group studyJ M Quagliana, R L Stephens, L H Baker, et al.Cancer Treatment Reports|November 1, 1979
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lungR J Fraile, M K Samson, L H Baker, et al.Journal of Chromatography|January 13, 1984
High-performance liquid chromatographic determination of nafazatrom in human plasma using fluorescence detectionL J Evans, J D Young, J S Hutchison, et al.Pageof 41